Background: A prospective, multicenter trial was undertaken to assess the activity, safety, and quality of life of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer (MBC). Patients and methods: Fifty-two women with HER2-negative MBC who were candidates for second-line chemotherapy for the metastatic disease were enrolled and treated at three centers in Northern Italy. All patients had previously received taxane-based chemotherapy in the adjuvant or first-line metastatic setting. Single-agent nab-paclitaxel was given at the dose of 260 mg/m2 as a 30-minute intravenous infusion on day 1 each treatment cycle, which lasted 3 weeks, in the outpatient se...
PURPOSE The GeparSepto trial demonstrated that weekly nanoparticle albumin-bound (NAB)-paclitaxel si...
Nab-paclitaxel is a novel Cremophor®-free nanoparticle of albumin-stabilized paclitaxel, which has f...
The optimal sequence of systemic chemotherapy in metastatic breast cancer (MBC) is unknown. We repor...
The therapeutic goals in metastatic breast cancer (MBC) remain palliative in nature, aimed at contro...
The therapeutic goals in metastatic breast cancer (MBC) remain palliative in nature, aimed at contro...
Background: There is a deep need to improve the care of metastatic breast cancer (MBC) patients, sin...
Abstract: The taxanes, paclitaxel and docetaxel, are an important class of antineoplastic agents wit...
Taxanes are highly active chemotherapeutic agents in the treatment of early-stage and metastatic bre...
Introduction: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is a novel solvent-free formula...
Introduction: Docetaxel and paclitaxel are among the most active agents for the treatment of breast ...
ABI-007 is a novel nanoparticle, albumin-bound paclitaxel that is free of solvents. This multicenter...
Weekly administration of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) has been shown to be...
Objective This study compared the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-...
BACKGROUND Unresectable locally advanced or metastatic triple-negative (hormone-receptor-negative an...
Si Sun,1 Lichen Tang,2 Jian Zhang,1 Fangfang Lv,1 Zhonghua Wang,1 Leiping Wang,1 Qunling Zhang,1 Chu...
PURPOSE The GeparSepto trial demonstrated that weekly nanoparticle albumin-bound (NAB)-paclitaxel si...
Nab-paclitaxel is a novel Cremophor®-free nanoparticle of albumin-stabilized paclitaxel, which has f...
The optimal sequence of systemic chemotherapy in metastatic breast cancer (MBC) is unknown. We repor...
The therapeutic goals in metastatic breast cancer (MBC) remain palliative in nature, aimed at contro...
The therapeutic goals in metastatic breast cancer (MBC) remain palliative in nature, aimed at contro...
Background: There is a deep need to improve the care of metastatic breast cancer (MBC) patients, sin...
Abstract: The taxanes, paclitaxel and docetaxel, are an important class of antineoplastic agents wit...
Taxanes are highly active chemotherapeutic agents in the treatment of early-stage and metastatic bre...
Introduction: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is a novel solvent-free formula...
Introduction: Docetaxel and paclitaxel are among the most active agents for the treatment of breast ...
ABI-007 is a novel nanoparticle, albumin-bound paclitaxel that is free of solvents. This multicenter...
Weekly administration of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) has been shown to be...
Objective This study compared the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-...
BACKGROUND Unresectable locally advanced or metastatic triple-negative (hormone-receptor-negative an...
Si Sun,1 Lichen Tang,2 Jian Zhang,1 Fangfang Lv,1 Zhonghua Wang,1 Leiping Wang,1 Qunling Zhang,1 Chu...
PURPOSE The GeparSepto trial demonstrated that weekly nanoparticle albumin-bound (NAB)-paclitaxel si...
Nab-paclitaxel is a novel Cremophor®-free nanoparticle of albumin-stabilized paclitaxel, which has f...
The optimal sequence of systemic chemotherapy in metastatic breast cancer (MBC) is unknown. We repor...